MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors
MetaVia Inc. has just pulled off a dramatic reset. After a 1‑for‑11 reverse stock split and a burst of upbeat clinical news, the tiny cardiometabolic biotech has seen its share price jump into the single digits again — but the business is still early‑stage, loss‑making, and highly speculative.